Hodgson Y M, Urquhart G, de Kretser D M
J Reprod Fertil. 1983 Jul;68(2):295-304. doi: 10.1530/jrf.0.0680295.
A single s.c. injection of hCG (100 i.u.) produced a biphasic serum testosterone response in adult male rats, peaks being noted at 2 h (24 ng/ml) and 3 days (16 ng/ml). The levels fell to control during the intervening interval (8 ng/ml), although there were elevated levels of serum hCG. Maintenance of high oestradiol levels by a s.c. injection of 50 micrograms oestradiol benzoate given on Day 2 after the initial hCG injection failed to prolong the refractory period and the secondary peak of testosterone (16 ng/ml) occurred on Day 3. Administration of the antioestrogen, tamoxifen (2 mg or 3 micrograms), 24 h before or simultaneously with hCG did not prevent testicular refractoriness in vivo because serum testosterone levels still declined after 2 h to reach a nadir at 2 days. The basal in-vitro testosterone production by decapsulated testes from animals injected with hCG was enhanced at 2 h. Stimulation by hCG increased the amount of testosterone produced (X 1.5 that in controls). By 12 h basal production decreased and there was no further increment in testosterone in the presence of hCG. This refractoriness to further hCG stimulation prevailed until Day 3, but the total production of testosterone fell so that at 24 h and 2 days testes were producing basal amounts of testosterone. Testes recovered from refractoriness at 4 and 5 days, when basal and stimulated testosterone production were greater than in controls. Injection of 50 micrograms oestradiol benzoate at 2 days did not prolong the in-vitro refractory period and 2 mg or 3 micrograms tamoxifen had no effect on the in-vitro steroidogenic activity, since testes were still refractory to further hCG stimulation from 12 h to 3 days. The results of the present study do not support the hypothesis that oestradiol is involved in the hCG-induced refractoriness of the Leydig cell. The nadir between the peaks of serum testosterone in vivo corresponds to the period during which the testis is refractory to in-vitro stimulation by hCG.
对成年雄性大鼠单次皮下注射人绒毛膜促性腺激素(hCG,100国际单位)会产生双相血清睾酮反应,在2小时(24纳克/毫升)和3天(16纳克/毫升)时出现峰值。尽管血清hCG水平升高,但在此间隔期内(8纳克/毫升)水平降至对照值。在首次注射hCG后第2天皮下注射50微克苯甲酸雌二醇以维持高雌二醇水平,未能延长不应期,睾酮的第二个峰值(16纳克/毫升)仍出现在第3天。在hCG注射前24小时或同时给予抗雌激素药物他莫昔芬(2毫克或3微克),并不能在体内防止睾丸不应期,因为血清睾酮水平在2小时后仍会下降,并在2天时达到最低点。注射hCG的动物去包膜睾丸的基础体外睾酮生成在2小时时增强。hCG刺激增加了睾酮的生成量(是对照的1.5倍)。到12小时时基础生成量下降,在有hCG存在的情况下睾酮不再进一步增加。这种对进一步hCG刺激的不应期一直持续到第3天,但睾酮的总生成量下降,以至于在24小时和2天时睾丸产生基础量的睾酮。睾丸在4天和5天时从不应期恢复,此时基础和刺激后的睾酮生成量均高于对照。在第2天注射50微克苯甲酸雌二醇并不能延长体外不应期,2毫克或3微克他莫昔芬对体外类固醇生成活性没有影响,因为从12小时到3天睾丸对进一步的hCG刺激仍不应。本研究结果不支持雌二醇参与hCG诱导的睾丸间质细胞不应期这一假说。体内血清睾酮峰值之间的最低点对应于睾丸对hCG体外刺激不应的时期。